Science Explorer Back to mapMap
Discussion
Researcher · Oregon Health & Science University · United States

Mark L. Fuerst

Mark L. Fuerst publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Hematology, on topics such as Chronic Lymphocytic Leukemia Research, Cancer Immunotherapy and Biomarkers and Hepatitis C virus research.

OpenAlex
World rank
#7,710,266
of 7,710,434 ranked researchers
Rank in United States
#1,627,009
of 1,627,098
Works
1,039
Citations
140
Citations per work
0.1
h-index
6
i10-index 1Top 84% in Oncology
Mark L. Fuerst

What does Mark L. Fuerst research?

Mark L. Fuerst's work is mostly in Medicine (37%), Biochemistry, Genetics and Molecular Biology (5%).

Everything else: 606 works · 58.3% of their workHealth Sciences: 384 works · 37.0% of their workMedicine: 384 works · 37.0% of their workOncology: 149 works · 14.3% of their workPulmonary and Respiratory Medicine: 92 works · 8.9% of their workHematology: 62 works · 6.0% of their workEpidemiology: 42 works · 4.0% of their workSurgery: 39 works · 3.8% of their workLife Sciences: 49 works · 4.7% of their workBiochemistry, Genetics and Molecular Biology: 49 works · 4.7% of their workMolecular Biology: 49 works · 4.7% of their workTHEIR WORKMark L. Fuerst1,039works
Life Sciences5%Health Sciences37%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else60658.3%
    1. Medicine38437.0%
    1. Biochemistry, Genetics and Molecular Biology494.7%
  1. 1Oncology14% of their works
  2. 2Pulmonary and Respiratory Medicine9% of their works
  3. 3Hematology6% of their works
  4. 4Molecular Biology5% of their works
  5. 5Epidemiology4% of their works
  6. 6Surgery4% of their works

Research topics

Which keywords describe Mark L. Fuerst's research?

The keywords of their largest research topics: Rituximab, Lymphoma, Chronic Lymphocytic Leukemia, Genomic Aberrations, Immune Checkpoint Blockade, PD-1 and PD-L1, Hepatitis C Virus and Treatment.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Rituximab1122 topics
  2. Lymphoma942 topics
  3. Chronic Lymphocytic Leukemia691 topic
  4. Genomic Aberrations691 topic
  5. Immune Checkpoint Blockade651 topic
  6. PD-1 and PD-L1651 topic
  7. Hepatitis C Virus571 topic
  8. Treatment571 topic
  9. CAR T Cells511 topic
  10. Chimeric Antigen Receptor511 topic
  11. BCR-ABL471 topic
  12. Imatinib471 topic
  13. Classification431 topic
  14. Molecular Profiling431 topic
  15. Cancer Genomics401 topic
  16. Mutational Signatures401 topic
  17. Diagnosis Criteria391 topic
  18. International Myeloma Working Group391 topic

Where does Mark L. Fuerst work?

Mark L. Fuerst's main affiliation in the publication record is Oregon Health & Science University, United States.

How many publications and citations does Mark L. Fuerst have?

OpenAlex counts 1,039 works and 140 citations for Mark L. Fuerst, an h-index of 6, ranking #7,710,266 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mark L. Fuerst. Posts are plain text and can be reported.